Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jul 24 | ALMS Alumis Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 16 | 38,000 | 608.00 k | 38,000 |
1 Jul 24 | ALMS Alumis Inc. Common Stock | Stock Option Class A Common Stock | Sale back to company | Dispose D | No | No | 16 | 38,000 | 608.00 k | 0 |
27 Jun 24 | ALMS Alumis Inc. Common Stock | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 16 | 38,000 | 608.00 k | 38,000 |
17 Jun 24 | ADVM Adverum Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 7.32 | 3,300 | 24.16 k | 3,300 |
17 Jun 24 | ADVM Adverum Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 7.32 | 10,520 | 77.01 k | 10,520 |
7 Jun 24 | SLRN Acelyrin | Director Stock Option Common Stock | Grant | Acquire A | No | No | 4.46 | 92,158 | 411.02 k | 92,158 |
6 Jun 24 | RCUS Arcus Biosciences | Common Stock | Grant | Acquire A | No | No | 0 | 8,400 | 0.00 | 25,300 |
6 Jun 24 | RCUS Arcus Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 15.9 | 24,000 | 381.60 k | 24,000 |